Codex Biosciences International Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 30-07-2024
- Paid Up Capital ₹ 2.61 M
as on 30-07-2024
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.70 Cr
as on 30-07-2024
- Satisfied Charges ₹ 3.02 Cr
as on 30-07-2024
- Revenue -27.21%
(FY 2023)
- Profit -41.46%
(FY 2023)
- Ebitda -99.14%
(FY 2023)
- Net Worth 7.55%
(FY 2023)
- Total Assets -1.29%
(FY 2023)
About Codex Biosciences International
The Corporate was formerly known as Coion Technologies Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.61 M.
The company currently has active open charges totaling ₹3.70 Cr. The company has closed loans amounting to ₹3.02 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vidya Challagulla and Rajakumari Challagulla serve as directors at the Company.
- CIN/LLPIN
U51397AP2000PTC033511
- Company No.
033511
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Codex Biosciences International Private Limited offer?
Codex Biosciences International Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement.
Who are the key members and board of directors at Codex Biosciences International?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vidya Challagulla  | Managing Director | 09-Feb-2000 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajakumari Challagulla | Director | 30-Nov-2001 | Current |
Financial Performance of Codex Biosciences International.
Codex Biosciences International Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.21% decrease. The company also saw a substantial fall in profitability, with a 41.46% decrease in profit. The company's net worth moved up by a moderate rise of 7.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Codex Biosciences International?
In 2023, Codex Biosciences International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cnn Properties LlpActive 1 year 8 monthsVidya Challagulla and Rajakumari Challagulla are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Jan 2023 | ₹4.50 M | Open |
Others Creation Date: 08 Apr 2022 | ₹2.90 M | Open |
Others Creation Date: 16 Sep 2020 | ₹3.30 M | Open |
How Many Employees Work at Codex Biosciences International?
Codex Biosciences International has a workforce of 20 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Codex Biosciences International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Codex Biosciences International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
.webp){kind=small}
